COLUMBUS CIRCLE INVESTORS - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
COLUMBUS CIRCLE INVESTORS ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$8,071,000
-41.0%
80,990
-32.0%
0.44%
-24.5%
Q4 2019$13,687,000
+16.4%
119,122
+27.8%
0.59%
+36.1%
Q3 2019$11,759,000
+29.9%
93,224
+23.9%
0.43%
+78.5%
Q2 2019$9,054,000
-63.4%
75,234
-69.6%
0.24%
-65.5%
Q4 2018$24,744,000
-28.4%
247,320
-18.0%
0.70%
+1.6%
Q3 2018$34,575,000
+47.9%
301,752
+15.8%
0.69%
+42.9%
Q2 2018$23,378,000
+60.3%
260,678
+30.8%
0.48%
+63.2%
Q1 2018$14,581,000199,3030.30%
Other shareholders
HAEMONETICS CORP shareholders Q1 2018
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders